Smad3 Is a Key Nonredundant Mediator of Transforming Growth Factor β Signaling in Nme Mouse Mammary Epithelial Cells

Smad2 and Smad3 are intracellular mediators of transforming growth factor β (TGFβ) signaling that share various biochemical properties, but data emerging from functional analyses in several cell types indicate that these two Smad proteins may convey distinct cellular responses. Therefore, we have investigated the individual roles of Smad2 and Smad3 in mediating the cytostatic and proapoptotic effects of TGFβ as well as their function in epithelial-to-mesenchymal transition. For this purpose, we transiently depleted mouse mammary epithelial cells (Nme) of Smad2 and/or Smad3 mainly by a strategy relying on RNaseH-induced degradation of mRNA. The effect of such depletion on hallmark events of TGFβ-driven epithelial-to-mesenchymal transition was analyzed, including dissolution of epithelial junctions, formation of stress fibers and focal adhesions, activation of metalloproteinases, and transcriptional regulation of acknowledged target genes. Furthermore, we investigated the effect of Smad2 and Smad3 knockdown on the TGFβ-regulated transcriptome by microarray analysis. Our results identify Smad3 as a key factor to trigger TGFβ-regulated events and ascribe tumor suppressor as well as oncogenic activities to this protein. (Mol Cancer Res 2009;7(8):1342–53)

[1]  E. Bottinger,et al.  Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. , 2008, The Journal of clinical investigation.

[2]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[3]  Liang Zhang,et al.  Identification of the gene transcription and apoptosis mediated by TGF‐β‐Smad2/3‐Smad4 signaling , 2008, Journal of cellular physiology.

[4]  Charis Eng,et al.  Direct evidence for epithelial-mesenchymal transitions in breast cancer. , 2008, Cancer research.

[5]  H. Matsui,et al.  Reversible Smad-dependent signaling between tumor suppression and oncogenesis. , 2007, Cancer research.

[6]  T. P. Prakash,et al.  2'-Modified oligonucleotides for antisense therapeutics. , 2007, Current topics in medicinal chemistry.

[7]  P. ten Dijke,et al.  The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. , 2006, Cancer research.

[8]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[9]  C. Hill,et al.  Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. , 2006, Cytokine & growth factor reviews.

[10]  K. Flanders,et al.  Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. , 2006, Cytokine & growth factor reviews.

[11]  N. Wahab,et al.  The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. , 2006, The Biochemical journal.

[12]  R. Kucherlapati,et al.  Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation , 2006, Molecular and Cellular Biology.

[13]  J. Massagué,et al.  Smad transcription factors. , 2005, Genes & development.

[14]  Sang Gyun Kim,et al.  The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3. , 2005, Molecular biology of the cell.

[15]  H. Beug,et al.  Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.

[16]  M. Gleave,et al.  Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic , 2005, International journal of urology : official journal of the Japanese Urological Association.

[17]  Jiri Zavadil,et al.  TGF-β and epithelial-to-mesenchymal transitions , 2005, Oncogene.

[18]  C. Heldin,et al.  Non-Smad TGF-β signals , 2005, Journal of Cell Science.

[19]  D. Huylebroeck,et al.  Smads and chromatin modulation. , 2005, Cytokine & growth factor reviews.

[20]  Rafael A. Irizarry,et al.  Bioinformatics and Computational Biology Solutions using R and Bioconductor , 2005 .

[21]  C. Heldin,et al.  TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. , 2005, Molecular biology of the cell.

[22]  Ming-Hai Wang,et al.  Activation of the RON receptor tyrosine kinase attenuates transforming growth factor-beta1-induced apoptotic death and promotes phenotypic changes in mouse intestinal epithelial cells. , 2004, Carcinogenesis.

[23]  P. Dijke,et al.  New insights into TGF-β–Smad signalling , 2004 .

[24]  K. Flanders,et al.  Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. , 2004, The American journal of pathology.

[25]  A. Klippel,et al.  Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4 , 2003, Oncogene.

[26]  R. Kucherlapati,et al.  Hierarchical model of gene regulation by transforming growth factor β , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  L. Nelles,et al.  Interaction between Smad-interacting Protein-1 and the Corepressor C-terminal Binding Protein Is Dispensable for Transcriptional Repression of E-cadherin* , 2003, Journal of Biological Chemistry.

[28]  Jens Kurreck,et al.  Antisense technologies. Improvement through novel chemical modifications. , 2003, European journal of biochemistry.

[29]  C. Heldin,et al.  Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced Responses* , 2003, The Journal of Biological Chemistry.

[30]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[31]  F. Leenders,et al.  GeneBlocs are powerful tools to study and delineate signal transduction processes that regulate cell growth and transformation. , 2002, Antisense & nucleic acid drug development.

[32]  R. Kucherlapati,et al.  Functional Characterization of Transforming Growth Factor β Signaling in Smad2- and Smad3-deficient Fibroblasts* , 2001, The Journal of Biological Chemistry.

[33]  G. Berx,et al.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.

[34]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[35]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[36]  佐藤 三佐子.  Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction , 2005 .

[37]  J. Kurreck.  Improvement through novel chemical modifications , 2003 .

[38]  H. Moses,et al.  Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. , 2001, Molecular biology of the cell.